Just confirmed an already bad situation to anyone paying attention.
IsoPet is hopeless, but we already knew that. Revenues declining, and what IsoPet is sold, is sold well below cost. The crime is MK continues to waste $ and time on this distraction at expense of getting Radiogel to human trials, which is only thing that matters now.
Cash situation is bad, but again, not a surprise. Last offering has already been burned through. About 7, maybe 8, months worth of cash remains. maybe less. So looks like there will have to be another offering soon at very poor terms before IDE submission.
Best thing would be for MK to be immediately replaced with competent management. That alone would boost confidence and atm pps to yield much better terms on the next offering and give us a fighting chance of getting Radiogel to human trials.